Literature DB >> 19320896

Circulating monocytes have the capacity to be transdifferentiated into keratinocyte-like cells.

Abelardo Medina1, Erin Brown, Nicholas Carr, Aziz Ghahary.   

Abstract

Transdifferentiation is a process in which the original commitment of a cell is changed to give rise to unexpected peripheral mature cells. Our previous report showed that circulating stem cells can generate keratinocyte-like cells (KLCs). However, it remains to be determined whether or not other peripheral blood mononuclear cells (PBMC) subsets have the potential to follow the same cell fate. In this study, the cell transdifferentiation of circulating CD14(+) monocytes into KLCs and their regulatory effect on matrix metalloproteinase-1 (MMP-1) expression in dermal fibroblasts were evaluated. The results showed that monocytes isolated from peripheral blood mononuclear cells have the capacity to generate KLCs. These transdifferentiated cells exhibited, along with a keratinocyte-like morphology, a characteristic profile consisting in stratifin(+), cytokeratins(+) (types I and II), CD14(low), and involucrin(+) on day 21 in culture. Similar to keratinocyte-conditioned media, KLC-derived conditioned media were able to induce an increase in the MMP-1 expression in dermal fibroblasts. This effect was significantly reduced by using 14-3-3 protein-depleted KLC-conditioned media. Our findings show the potential transdifferentiation of circulating CD14(+) monocytes into KLCs and their regulatory effect on MMP-1 expression in dermal fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19320896     DOI: 10.1111/j.1524-475X.2009.00457.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  9 in total

Review 1.  Peripheral blood stem cells: phenotypic diversity and potential clinical applications.

Authors:  Yichi Zhang; Bing Huang
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

2.  Reprogrammed fibrocytes induce a mixed Th1/Th2 cytokine response of naïve CD4(+) T cells.

Authors:  Abelardo Medina; Aziz Ghahary
Journal:  Mol Cell Biochem       Date:  2010-10-05       Impact factor: 3.396

3.  Fibrocytes can be reprogrammed to promote tissue remodeling capacity of dermal fibroblasts.

Authors:  Abelardo Medina; Aziz Ghahary
Journal:  Mol Cell Biochem       Date:  2010-06-20       Impact factor: 3.396

4.  Monocytes infiltrate the pancreas via the MCP-1/CCR2 pathway and differentiate into stellate cells.

Authors:  Kazuko Ino; Masahiro Masuya; Isao Tawara; Eri Miyata; Keiko Oda; Yoshiki Nakamori; Kei Suzuki; Kohshi Ohishi; Naoyuki Katayama
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

5.  Priming of mononuclear cells with a combination of growth factors enhances wound healing via high angiogenic and engraftment capabilities.

Authors:  Enze Jin; Jong-Min Kim; Sung-Whan Kim
Journal:  J Cell Mol Med       Date:  2013-10-09       Impact factor: 5.310

6.  Differentiated fibrocytes assume a functional mesenchymal phenotype with regenerative potential.

Authors:  Changying Ling; Kohei Nishimoto; Zach Rolfs; Lloyd M Smith; Brian L Frey; Nathan V Welham
Journal:  Sci Adv       Date:  2019-05-08       Impact factor: 14.136

7.  Leucocyte-Rich Platelet-Rich Plasma Enhances Fibroblast and Extracellular Matrix Activity: Implications in Wound Healing.

Authors:  Jeannie Devereaux; Narges Dargahi; Sarah Fraser; Kulmira Nurgali; Dimitrios Kiatos; Vasso Apostolopoulos
Journal:  Int J Mol Sci       Date:  2020-09-06       Impact factor: 5.923

8.  Identification of p63+ keratinocyte progenitor cells in circulation and their matrix-directed differentiation to epithelial cells.

Authors:  Renjith P Nair; Lissy K Krishnan
Journal:  Stem Cell Res Ther       Date:  2013-04-11       Impact factor: 6.832

9.  Platelets and smooth muscle cells affecting the differentiation of monocytes.

Authors:  Michelle W Y Williams; Ann K Guiffre; John P Fletcher
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.